Our discovery that Nup358 is required for the differentiation of myeloid-biased MPPs not only provides the first insights into how nucleoporins contribute to the regulation of blood development but could help to establish how alterations in Nup358 function contribute to myeloid malignancies. This evidence concerns the gene RANBP2 and myeloid neoplasm.